Dobutamine Hydrochloride Injection — FDA Drug Shortage

Current — Hainan Poly Pharm. Co., Ltd.

The FDA lists a drug shortage record for Dobutamine Hydrochloride Injection (injection) from Hainan Poly Pharm. Co., Ltd. with status Current. The shortage was first posted on Nov 6, 2017.

Shortage details

Status
Current
Company
Hainan Poly Pharm. Co., Ltd.
Package NDC
70436-203-80
Dosage Form
Injection
Presentation
Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)
Initial Posting
Nov 6, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.